| MolName | 3-[[1-[(Z)-(3,5-dioxo-1-phenylpyrazolidin-4-ylidene)methyl]naphthalen-2-yl]oxymethyl]benzoic acid |
| MolecularFormula | C28H20N2O5 |
| Smiles | OC(c1cccc(COc2c(/C=C(/C(NN3c4ccccc4)=O)\C3=O)c3ccccc3cc2)c1)=O |
| InChI | InChI=1S/C28H20N2O5/c31-26-24(27(32)30(29-26)21-10-2-1-3-11-21)16-23-22-12-5-4-8-19(22)13-14-25(23)35-17-18-7-6-9-20(15-18)28(33)34/h1-16H,17H2,(H,29,31)(H,33,34) |
| InChIK | UYPCNKADLJPJCJ-UHFFFAOYSA-N |
| TotalMolweight | 464.476 |
| Molweight | 464.476 |
| MonoisotopicMass | 464.137223 |
| CLogP | 3.3712 |
| CLogS | -5.85 |
| H Acceptors | 7 |
| H Donors | 2 |
| TotalSurfaceArea | 343.71 |
| Relative PSA | 0.2247 |
| PolarSurfaceArea | 95.94 |
| Druglikeness | 3.7152 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.48571 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 7 |
| Electronegative Atoms | 7 |
| Rotatable Bond | 6 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 22 |
| Sp3Atoms | 3 |
| Symmetricatoms | 2 |
| AcidicOxygens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 3-[[1-[(Z)-(3,5-dioxo-1-phenylpyrazolidin-4-ylidene)methyl]naphthalen-2-yl]oxymethyl]benzoic acid | 2 - 3-[[1-[(Z)-(3,5-dioxo-1-phenylpyrazolidin-4-ylidene)methyl]naphthalen-2-yl]oxymethyl]benzoic acid